| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/28/2002 | US20020026235 Prosthetic grafts |
| 02/28/2002 | US20020025577 Eukaryotic gene expression cassette and uses thereof |
| 02/28/2002 | US20020025562 Plasma-like solution |
| 02/28/2002 | US20020025516 Nrde |
| 02/28/2002 | US20020025327 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 02/28/2002 | US20020025309 Stable oral pharmaceutical formulation containing an anti-infective agent and a microorganism |
| 02/28/2002 | US20020025308 Composition for the delivery of live cells and methods of use |
| 02/28/2002 | US20020025307 Gene therapy, testing |
| 02/28/2002 | US20020025306 Providing a source of a glucoincretin that increases the responsiveness of the cell to glucose |
| 02/28/2002 | CA2456008A1 Stem cell differentiation |
| 02/28/2002 | CA2420901A1 Scaffolds for tissue engineered hair |
| 02/28/2002 | CA2420261A1 Genes and proteins, and their uses |
| 02/28/2002 | CA2420260A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
| 02/28/2002 | CA2420194A1 Use of a porous carrier |
| 02/28/2002 | CA2420087A1 Cripto tumour polypeptide |
| 02/28/2002 | CA2419981A1 Coaster, a human coactivator of steroid receptors |
| 02/28/2002 | CA2419923A1 Vascularised tissue graft |
| 02/28/2002 | CA2419454A1 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 02/28/2002 | CA2418461A1 Method and compositions for promoting osteogenesis |
| 02/27/2002 | EP1182209A2 A method for extraction and purification of cartilage type proteoglycan |
| 02/27/2002 | EP1181382A2 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 02/27/2002 | EP1181381A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 02/27/2002 | EP1181376A2 Gene construct for prodrug activation encoding a heterologous, glycosylphophatidylinositol-modified carboxypeptidase g2 and a cell surface targeting signal peptide |
| 02/27/2002 | EP1181354A1 Method for multiplying stem cells |
| 02/27/2002 | EP1181320A2 Somatic transgene immunization and related methods |
| 02/27/2002 | EP1181318A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 02/27/2002 | EP1181317A1 An integrin heterodimer and an alpha subunit thereof |
| 02/27/2002 | EP1181312A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
| 02/27/2002 | EP1181057A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| 02/27/2002 | EP1181056A1 Lim mineralization protein splice variants |
| 02/27/2002 | EP1181051A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF IMMUNOLOGICALLY-MEDIATED DISEASES USING i MYCOBACTERIUM VACCAE /i |
| 02/27/2002 | EP1181050A1 Methods for preventing reactivation of latent virus and controlling virus replication |
| 02/27/2002 | EP1181047A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 02/27/2002 | EP1181027A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 02/27/2002 | EP1181026A2 Improved method for treating mammals with modified mammalian blood |
| 02/27/2002 | EP1181025A2 Molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy |
| 02/27/2002 | EP1180940A2 Active agent and combination of active agents for human beings and animals |
| 02/27/2002 | EP1180938A2 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 02/27/2002 | EP1180937A1 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
| 02/27/2002 | EP1180932A1 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 02/27/2002 | EP0836380B1 Fgf9 as a specific ligand for fgfr3 |
| 02/27/2002 | EP0831887B1 Therapy using lymphotoxin and thrombopoietin |
| 02/27/2002 | EP0827545B1 Retroviral vectors |
| 02/27/2002 | CN1337263A Kidney invigorating and Yang strenthening medicine and its prepn |
| 02/27/2002 | CN1337262A Wind dispelling and cold expelling snake ointment |
| 02/27/2002 | CN1337261A Wudu ointment |
| 02/27/2002 | CN1337260A Prepn of piles eliminating medicine liquid |
| 02/27/2002 | CN1337259A Prepn of piles eliminating medicine liquid |
| 02/27/2002 | CN1337254A Cancer-treating Chinese medicine and its prepn |
| 02/27/2002 | CN1337251A 抗癌胶囊 Anticancer Capsules |
| 02/27/2002 | CN1337250A Compound Wuduqing capsule of blister beetle |
| 02/27/2002 | CN1337249A Liposoluble Chinese medicine rectal suppository for treating acute and chronic prostatitis |
| 02/27/2002 | CN1337245A Cold treating medicine |
| 02/27/2002 | CN1337236A External-use analgesic and its prepn |
| 02/27/2002 | CN1337235A Heart disease treating method with jade |
| 02/27/2002 | CN1079833C Recombinant P53 adenovirus method and compositions |
| 02/27/2002 | CN1079828C Tea fungus drink and making method thereof |
| 02/27/2002 | CN1079660C Miniming trichomadesis with anti-fungus compound and halogeno-anti-bacteria compound |
| 02/26/2002 | US6350890 Isolation of fatty acids or fatty esters from reaction |
| 02/26/2002 | US6350575 Helper viruses for the preparation of recombinant viral vectors |
| 02/26/2002 | US6350472 Method of treating HIV infection with transdermal gel containing mammalian liver extract |
| 02/26/2002 | US6350467 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 02/26/2002 | US6350457 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 02/26/2002 | US6350444 Gene therapy for pulmonary edema using adenovirus vectors encoding Na,K-ATPase |
| 02/26/2002 | CA2211727C Large area submucosal graft constructs and method for making the same |
| 02/21/2002 | WO2002014511A2 Regulation of human p2y1-like g protein-coupled receptor |
| 02/21/2002 | WO2002014481A1 Method of extensive culture of antigen-specific cytotoxic t cells |
| 02/21/2002 | WO2002014479A2 Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells |
| 02/21/2002 | WO2002014474A2 Method of treating alzheimer's disease with cell therapy |
| 02/21/2002 | WO2002014357A2 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage |
| 02/21/2002 | WO2002013982A1 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
| 02/21/2002 | WO2002013839A1 Animal papilla disinfectants and method of improving microbial environment |
| 02/21/2002 | WO2002013838A1 Seal-oil-based pharmaceutical, cosmetic, dermo-cosmetic, hygiene, alimentary and para-alimentary (food-supplements) products; their methods of preparation; their uses as preventive and/or as therapeutic agents |
| 02/21/2002 | WO2002013837A1 A novel animal model of alzheimer's disease using genetically altered stem cells |
| 02/21/2002 | WO2002013760A2 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 02/21/2002 | WO2001083698A3 Compositions and methods for inducing activation of dendritic cells |
| 02/21/2002 | WO2001079443A3 Albumin fusion proteins |
| 02/21/2002 | WO2001078533A3 Nutritional modules |
| 02/21/2002 | WO2001074491A3 Eggshell waste processing method and device |
| 02/21/2002 | WO2001064240A3 Methods for promoting production of myelin by schwann cells |
| 02/21/2002 | WO2001062901A3 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 02/21/2002 | WO2001059076A3 Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses |
| 02/21/2002 | WO2001057069A3 Targeting peptides |
| 02/21/2002 | WO2001055391A3 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001054711A3 Use of neurotoxins for treating diabetes |
| 02/21/2002 | WO2001044282A3 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 02/21/2002 | WO2001039722A3 B7-h1, a novel immunoregulatory molecule |
| 02/21/2002 | WO2001019158A3 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 02/21/2002 | WO2000069269A9 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
| 02/21/2002 | US20020022592 Delivery of thrombospondin from implantable tissue matrices |
| 02/21/2002 | US20020022268 Culturing primate progenitor tissues; obtain tissues, harvest nutrients from culture, monitor tissue propagation |
| 02/21/2002 | US20020022248 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 02/21/2002 | US20020022053 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related thereto |
| 02/21/2002 | US20020022036 Administering high molecular weight urine isolate; anticancer, Aids therapy |
| 02/21/2002 | US20020022020 Induction lymphocyte tolerance |
| 02/21/2002 | US20020022019 Method of reducing ecologically adverse changes of the gastro intestinal microbial flora in patients under treatment with medicaments |
| 02/21/2002 | DE10038700A1 Autologe Bindegewebe, Verfahren zu ihrer Herstellung und ihre Verwendung Autologous connective tissue, processes for their preparation and their use |
| 02/21/2002 | CA2423592A1 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 02/21/2002 | CA2418240A1 A disinfectant for teats of animals, and a method for improving microorganism-enviroment harmful for animals |
| 02/20/2002 | EP1180159A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |